Biolink Group’s main operating area is R&D within Life Science, covering Nutraceuticals and other health promoting applications, on natural and synthesized, patented anthocyanin molecules. Clinical research based on the natural anthocyanin molecules and the Nutraceutical Medox® has taken place since the year 2000.


Biolink Group promotes synthesized anthocyanins for commercial, industrial applications within Life Science.
Biolink Group`s consumer-based operation is developing, processing and marketing the professional Nutraceutical product, Medox®. This unique scientific clinically documented product is based on catechol-structured strong health promoting anthocyanins. Medox® is mainly marketed through professional health care workers.